Today: 24 May 2026
Reckitt Benckiser share price dips after Philippines recall scare; RKT eyes dividend vote
27 January 2026
1 min read

Reckitt Benckiser share price dips after Philippines recall scare; RKT eyes dividend vote

London, 08:15 GMT, January 27, 2026 — Regular session

  • Shares of Reckitt slipped in early London trading after the company denied reports of a product recall in the Philippines.
  • The company said the infant formula cited in the article isn’t registered or sold domestically.
  • Traders are focused on an upcoming shareholder vote concerning a special dividend plan and a share consolidation.

Shares of Reckitt Benckiser Group (RKT.L) slipped about 0.3% to 5,938 pence in early London trading on Tuesday.

The move follows a brief spate of product safety headlines—precisely the type that consumer health groups tend to zero in on fast. Reckitt maintains there’s no issue, yet investors are cautious, watching the infant nutrition segment closely.

Reckitt is amid a busy stretch of corporate actions and capital returns. In this environment, even a brief rumour can divert attention — and money — away from the bigger story.

Reckitt pushed back Monday in a regulatory filing, denying any product recall in the Philippines. The company said a recent media report was inaccurate. It pointed out that the Mead Johnson Nutrition product mentioned — Enfamil ProSobee Simply Plant-Based Infant Formula — “is not registered and marketed in the Philippines.” Investegate

Reckitt’s daily buyback update Tuesday morning showed the firm repurchased 51,050 shares on Jan. 26. The volume-weighted average price was 5,876.10 pence, with individual shares bought for as low as 5,736 pence.

On Monday, another filing showed the group snapped up 49,670 shares on Jan. 23, at an average price of 6,038.33 pence apiece.

Reckitt’s lineup features consumer health and hygiene names such as Dettol, Finish, Lysol, and Durex, alongside its Mead Johnson Nutrition unit. The statement from the Philippines referred to just one product cited in the media report, not a wider change across the company’s range.

Still, the incident underscores the risks. The company hasn’t pinpointed where the report came from, and inquiries from regulators or retailers could keep the stock jittery. That holds, despite the group’s insistence that no recall is underway.

Reckitt is set for a crucial shareholder meeting on Tuesday to approve a 235 pence special dividend and a 24-for-25 share consolidation. The share consolidation will reduce the number of shares, aiming to keep the stock price stable after the cash payout linked to the Essential Home divestment. The company said it will announce the vote results once the meeting wraps up.

Reckitt is set to release its full-year results on March 5.

Stock Market Today

  • Humana (HUM) Stock Jumps Amid Conflicting Valuations and Medicare Oversight Concerns
    May 24, 2026, 6:13 AM EDT. Humana (HUM) shares rebounded sharply with a 43.08% gain over 30 days and nearly 70% over 90 days, closing at $307.95. Despite this short-term momentum, the stock is down 35.72% over three years. The market price exceeds some analyst targets by 44.7%, driven by concerns over tighter Medicare regulatory compliance impacting profit margins. However, discounted cash flow (DCF) models suggest a potential undervaluation, indicating a 68% discount and high intrinsic value estimates up to $964.87. Investors face a choice between weighing near-term regulatory risks and longer-term growth prospects as Medicare Advantage expands. The valuation debate highlights the evolving healthcare sector dynamics and the importance of compliance as a strategic operational focus.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 24.05.2026

24 May 2026
LIVEMarkets rolling coverageStarted: May 24, 2026, 4:00 AM EDTUpdated: May 24, 2026, 6:14 AM EDT Venture Global (VG) Valuation Under Scrutiny After Share Price Gains May 24, 2026, 6:14 AM EDT. Venture Global (NYSE: VG) shares surged nearly 2% following strong recent momentum, with a year-to-date gain near 96%. Despite a trading price of $13.83, models suggest the stock is about 13% overvalued, with a fair value estimated at $12.26. The valuation hinges on aggressive volume expansion plans, leveraging existing infrastructure to boost returns. VG’s price-to-earnings (P/E) ratio stands at 14.6, close to the fair ratio of 15.1 and below
Nifty Faces Oil Moves, Rupee and Short Week

Nifty Faces Oil Moves, Rupee and Short Week

24 May 2026
The Nifty 50 rose 0.27% Friday to 23,719.3 and the Sensex gained 0.31% to 75,415.35, but both indexes remain down sharply since the Iran war began. The rupee hit record lows, prompting Reserve Bank intervention, and foreign investors have sold $23 billion in Indian shares this year. Markets will close Thursday for Bakri Id, leaving four trading sessions in the week.
Australia Stock Market Today: ASX 200 Stalls Near 9,000 as NAB Slides, Oil Shock Keeps Traders on Edge. (Indo Premier)

ASX on Watch as Inflation Test Looms After Volatile Week

24 May 2026
The ASX 200 closed up 0.41% at 8,657 on Friday, gaining 0.3% for the week after volatile trading. Investors await April inflation data due Wednesday, seen as key for Reserve Bank of Australia rate expectations after weak April jobs figures cooled rate-hike bets. The Australian dollar traded at 71.36 U.S. cents late Friday. Miners and energy stocks led gains, while consumer and telecom shares fell.
National Grid’s North Sea “GriffinLink” plan puts its share price back in focus
Previous Story

National Grid’s North Sea “GriffinLink” plan puts its share price back in focus

BAE Systems share price ticks up on buyback update after Monday slide — what to watch next
Next Story

BAE Systems share price ticks up on buyback update after Monday slide — what to watch next

Go toTop